Creative Medical Technology Holdings, Inc. (CELZ): Operating Cash Flow
-$5.86M
Year ended 2025-12-31
-$5.90M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.86M | n/m | 2026-03-20, From 2025-01-01 |
| 2024-12-31 | -$5.30M | n/m | 2026-03-20, From 2024-01-01 |
| 2023-12-31 | -$8.03M | n/m | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | -$7.80M | n/m | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | -$2.22M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$434.6K | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$1.21M | n/m | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | -$1.05M | n/m | 2020-04-06, From 2018-01-01 |
| 2017-12-31 | -$889.6K | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$445.2K | n/m | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | -$14.6K | n/m | 2016-04-14, From 2015-01-01 |
| 2014-12-31 | -$17.3K | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$22.9K | n/m | 2015-02-27, From 2013-01-01 |
| 2012-12-31 | -$16.8K | n/m | 2014-03-17, From 2012-01-01 |
| 2011-12-31 | -$14.0K | n/m | 2013-03-15, From 2011-01-01 |
| 2010-12-31 | -$13.7K | n/a | 2012-03-26, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | 2025-12-31 | -$5.86M | n/m |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | -$43.44M | n/m |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | -$7.37M | n/m |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | -$22.58M | n/m |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | -$10.96M | n/m |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | -$10.83M | n/m |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | -$4.31M | n/m |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | -$61.99M | n/m |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | -$37.92M | n/m |
Compare CELZ, SNTI, ENTX, INMB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗